Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Diabetes Receiving Sulfonylurea Treatment: A Meta-analysis
出版年份 2021 全文链接
标题
Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Diabetes Receiving Sulfonylurea Treatment: A Meta-analysis
作者
关键词
CYP2C9, hypoglycemia, polymorphism, sulfonylurea, type 2 diabetes
出版物
CLINICAL THERAPEUTICS
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-09
DOI
10.1016/j.clinthera.2021.03.008
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical care
- (2020) Sabrina L. Mitchell et al. PHARMACOGENOMICS JOURNAL
- Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies
- (2018) Richard Silbert et al. Current Diabetes Reports
- Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms
- (2018) Agata Hanna Bryk et al. VASCULAR PHARMACOLOGY
- CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide
- (2018) Fayou Yang et al. Scientific Reports
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
- (2014) Jasna Klen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: A systematic review and meta-analysis
- (2013) Jie Yang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting
- (2011) Osman Gökalp et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia
- (2011) Andreas Holstein et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients
- (2011) A. Surendiran et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients
- (2010) Andreas Holstein et al. Expert Opinion On Drug Safety
- Presence ofCYP2C9*3allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
- (2009) Georgia Ragia et al. PHARMACOGENOMICS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Hypoglycaemia in Type 2 diabetes
- (2008) S. A. Amiel et al. DIABETIC MEDICINE
- Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
- (2008) Jonatan D. Lindh et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started